Atherogenesis, calcium and calcium antagonists

Area of Science:

• Cardiovascular Science
• Cellular Biology
• Pharmacology

Background:

• Hypercholesterolemia and arterial hypertension are key risk factors for atherosclerosis.
• Early atherosclerotic lesions in primates mirror those in children with high cholesterol.
• Atherogenesis involves calcium-regulated cellular processes like migration and lipid uptake.

Purpose of the Study:

• To investigate the role of cellular calcium in atherogenesis.
• To evaluate interventions targeting cell calcium uptake for preventing atherosclerosis.
• To assess the potential of calcium antagonists in treating coronary artery disease.

Main Methods:

• Studied nonhuman primates with dietary hypercholesterolemia.
• Examined interventions affecting cell calcium, including chelating agents and calcium antagonists.
• Reviewed controlled coronary angiographic trials in human patients.

Main Results:

• Interventions targeting cell calcium uptake retarded atherogenesis in animal models without affecting lipid levels.
• Calcium antagonists showed potential in slowing coronary atherosclerosis progression in human trials.

Conclusions:

• Cellular calcium regulation is crucial in atherogenesis.
• Calcium antagonists represent a potential therapeutic strategy for coronary atherosclerosis.
• Further large-scale, long-term studies are required to confirm the clinical utility of calcium antagonists.